RBC Life Sciences, Inc manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products ...
RBC Capital raised the firm’s price target on Edwards Lifesciences (EW) to $80 from $75 and keeps an Outperform rating on the shares. The firm expects Edwards to discuss its product and clinical ...
97.4% of Vestis shares are held by institutional investors. 45.8% of RBC Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback